Atherosclerosis, Coronary Clinical Trial
Official title:
A Phase 1, Feasibility Study Testing the Safety and Feasibility of Intracoronary CD34+ Cell Administration on Coronary Endothelial Function in Patients With Early Coronary Atherosclerosis
How safe and effective are CD34+ cell intracoronary injections for treating coronary endothelial dysfunction (CED)?
This is an open label, phase I study to determine safety and efficacy of CD34+ cells in the treatment and management of CED and early atherosclerosis. Coronary endothelial function will be assessed in all patients by the administration of intracoronary acetylcholine. Patients with endothelial dysfunction who meet study inclusion criteria will receive granulocyte cell stimulating factor (G-CSF), followed by apheresis. The mobilized peripheral cell product will be processed for selection of CD34+ stem cells, and the purified CD34+ cells will be administered intracoronary during cardiac catheterization. The patients will undergo repeat endothelial function assessment 6 months post-procedure, as well as clinical assessments as described below either via in-person assessment by a nurse or physician, or via phone-call using a standardized questionnaire at 1, 3, and 6 month follow-up visits. At one month, the patient will undergo basic laboratory testing including troponin levels, complete blood count (CBC), electrolyte panel, liver function testing and ECG. At 3 months, the patients will receive a phone follow-up by the study coordinator who will assess the patient for any clinical deterioration or significant worsening in symptoms. At 6 months, the patients will return for a clinical visit, which will include physical examination, basic laboratory testing and follow-up acetylcholine study with angiography to assess for change in endothelial function. The first three patients will be sequentially enrolled, and subsequent enrollment will be held until one month follow-up. Provided there are no safety concerns at this time, enrollment will continue. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03427996 -
Evaluation of Effectiveness and Safety of Rotational Atherectomy in Routine Clinical Practice
|
||
Not yet recruiting |
NCT04762472 -
Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China
|
Phase 4 | |
Not yet recruiting |
NCT03174418 -
Fluid-dynamics in Bifurcation PCI
|
N/A | |
Not yet recruiting |
NCT03813017 -
Comprehensive Assessment of Subclinical Atherosclerosis in Patients With Rheumatoid Arthritis
|
||
Recruiting |
NCT05600088 -
Intracoronary Cryotherapy Effect on Stabilization of Vulnerable Plaque in Patients With NSTEMI or Unstable Angina
|
N/A | |
Completed |
NCT03011775 -
Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
|
Phase 4 | |
Completed |
NCT00115583 -
The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
|
N/A | |
Completed |
NCT03149042 -
Validation of a Computed Tomography (CT) Based Fractional Flow Reserve (FFR) Software Using the 320 Detector Aquilion ONE CT Scanner.
|
||
Not yet recruiting |
NCT05540223 -
Safety and Clinical Performance of the DREAMS 3G Resorbable Magnesium Scaffold System
|
N/A | |
Completed |
NCT02389946 -
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
|
N/A | |
Completed |
NCT01234870 -
Comprehensive Evaluation of Ischemic Heart Disease Using MRI
|
Phase 2/Phase 3 | |
Completed |
NCT00353795 -
Coronary Atherosclerosis Evaluation by Arterial Wall Magnetic Resonance Imaging (MRI)
|
N/A | |
Enrolling by invitation |
NCT04810364 -
HIV Infection And Evolvement of Atherosclerotic Plaque
|
||
Active, not recruiting |
NCT04175626 -
Safety and Effectiveness of the Orsiro Sirolimus Eluting Coronary Stent System in Subjects With Coronary Artery Lesions
|
||
Recruiting |
NCT00146887 -
Comparison of Coronary CT Angiography to Invasive Coronary Angiography
|
N/A | |
Completed |
NCT05492084 -
Personalized Risk of Rapidly Progressive Atherosclerosis
|
||
Recruiting |
NCT04853511 -
Comprehensive Assessment of Interconnection Between Brain Emotional Activity and Coronary Plaque Instability
|
||
Completed |
NCT03815032 -
Assessing the Accuracy of the OptoWire DeuxTM in a Wire to Wire Comparison
|
N/A | |
Active, not recruiting |
NCT03129503 -
Optical Coherence Tomography in Acute Coronary Syndrome
|
||
Recruiting |
NCT06393894 -
Latvian Early Atherosclerosis Registry
|